Praziquantel

This classification denotes an antihelminthic agent with the molecular formula C19H24N2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6490C9U457, chemically known as 4h-pyrazino(2,1-a)isoquinolin-4-one, 2-(cyclohexylcarbonyl)-1,2,3,6,7,11b-hexahydro- but generally known as praziquantel, which bears US NIH Compound Identifier 4891. European Medicines Agency schedules Praziquantel in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10008MIG. The term PRAZIQUANTEL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 30, No. 10 1976, List 16). World Health Organization schedules praziquantel in its Anatomical Therapeutic Chemical (ATC) Classification. PRAZIQUANTEL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule praziquantel under HS 29335995 and SITC 51576. As of Q4 2014, PRAZIQUANTEL remains the US FDA Preferred Term for this commodity. Praziquantel bears US NLM identifiers UMLS ID C0032911 and NCI Concept Code C47683. SMILES: O=C(N1CC2N(CCC3C2CCCC3)C(=O)C1)C1CCCCC1.